Epirubicin plus ifosfamide and dacarbazine (EID) in advanced soft tissue sarcomas.
Casali
P
P
Division of Medical Oncology, Istituto Nazionale Tumori, Milano, Italy.
Pastorino
U
U
Zucchinelli
P
P
Devizzi
L
L
Azzarelli
A
A
Quagliuolo
V
V
Bignami
P
P
Santoro
A
A
Bonadonna
G
G
D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D003606:Dacarbazine / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D012509:Sarcoma / Q000188:drug therapy*; D012983:Soft Tissue Neoplasms / Q000188:drug therapy*
D015251:Epirubicin; D003606:Dacarbazine; D007069:Ifosfamide